These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 23749244)

  • 1. Prevalence of bisphosphonate-associated osteonecrosis of the jaw after intravenous zoledronate infusions in patients with early breast cancer.
    Rugani P; Luschin G; Jakse N; Kirnbauer B; Lang U; Acham S
    Clin Oral Investig; 2014; 18(2):401-7. PubMed ID: 23749244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of bisphosphonate-related osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies.
    Assaf AT; Smeets R; Riecke B; Weise E; Gröbe A; Blessmann M; Steiner T; Wikner J; Friedrich RE; Heiland M; Hoelzle F; Gerhards F
    Anticancer Res; 2013 Sep; 33(9):3917-24. PubMed ID: 24023329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of bisphosphonate-related osteonecrosis of the jaws in patients with prostate cancer treated with zoledronic acid - A prospective study over 6 years.
    Mücke T; Deppe H; Hein J; Wolff KD; Mitchell DA; Kesting MR; Retz M; Gschwend JE; Thalgott M
    J Craniomaxillofac Surg; 2016 Oct; 44(10):1689-1693. PubMed ID: 27555374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for bisphosphonate-associated osteonecrosis of the jaw in the prospective randomized trial of adjuvant bisphosphonates for early-stage breast cancer (SWOG 0307).
    Kizub DA; Miao J; Schubert MM; Paterson AHG; Clemons M; Dees EC; Ingle JN; Falkson CI; Barlow WE; Hortobagyi GN; Gralow JR
    Support Care Cancer; 2021 May; 29(5):2509-2517. PubMed ID: 32929540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonate-related osteonecrosis of jaw (BRONJ) in Japanese population: a case series of 13 patients at our clinic.
    Nomura T; Shibahara T; Uchiyama T; Yamamoto N; Shibui T; Yakushiji T; Watanabe A; Muramatsu K; Ogane S; Murayama M; Sekine R; Nakata E; Fujimoto Y
    Bull Tokyo Dent Coll; 2013; 54(2):117-25. PubMed ID: 23903583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zoledronate and osteonecrosis of the jaw in osteoporosis: incidence and risk factors. Analysis of the French Pharmacovigilance Database.
    Amigues C; Fresse A; Roux CH; Gauthier S; Vieillard MH; Drici MD; Breuil V;
    Joint Bone Spine; 2023 Dec; 90(6):105599. PubMed ID: 37271278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology, pharmacology and clinical characterization of bisphosphonate-related osteonecrosis of the jaw. A retrospective study of 70 cases.
    Pelaz A; Junquera L; Gallego L; García-Consuegra L; García-Martínez L; Cutilli T; Olay S
    Acta Otorrinolaringol Esp; 2015; 66(3):139-47. PubMed ID: 25308796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.
    O'Ryan FS; Khoury S; Liao W; Han MM; Hui RL; Baer D; Martin D; Liberty D; Lo JC
    J Oral Maxillofac Surg; 2009 Jul; 67(7):1363-72. PubMed ID: 19531404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of the early stages of intravenous bisphosphonate-related osteonecrosis of the jaw in patients with breast cancer.
    Matsuo A; Hamada H; Kaise H; Chikazu D; Yamada K; Kohno N
    Acta Odontol Scand; 2014 Nov; 72(8):656-63. PubMed ID: 24521290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonate-related osteonecrosis of the jaw (BRONJ) associated with a once-yearly IV infusion of zoledronic acid (Reclast) 5 mg: two cases and review of the literature.
    Katz J; Ordoveza PA
    Quintessence Int; 2014 Sep; 45(8):685-90. PubMed ID: 25019116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous bisphosphonate-related osteonecrosis of the jaw: long-term follow-up of 109 patients.
    Watters AL; Hansen HJ; Williams T; Chou JF; Riedel E; Halpern J; Tunick S; Bohle G; Huryn JM; Estilo CL
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Feb; 115(2):192-200. PubMed ID: 23036797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does regular zoledronic acid change the bone turnover of the jaw in men with metastatic prostate cancer: a possible clue to the pathogenesis of bisphosphonate related osteonecrosis of the jaw?
    Ristow O; Gerngroß C; Schwaiger M; Hohlweg-Majert B; Ristow M; Koerdt S; Schuster R; Otto S; Pautke C
    J Cancer Res Clin Oncol; 2014 Mar; 140(3):487-93. PubMed ID: 24469255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Model for Osteonecrosis of the Jaw with Zoledronate Treatment following Repeated Major Trauma.
    Howie RN; Borke JL; Kurago Z; Daoudi A; Cray J; Zakhary IE; Brown TL; Raley JN; Tran LT; Messer R; Medani F; Elsalanty ME
    PLoS One; 2015; 10(7):e0132520. PubMed ID: 26186665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of nonsurgical therapeutic management of stage I bisphosphonate-related osteonecrosis of the jaw.
    Bodem JP; Kargus S; Engel M; Hoffmann J; Freudlsperger C
    J Craniomaxillofac Surg; 2015 Sep; 43(7):1139-43. PubMed ID: 26116306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bisphosphonate-associated osteonecrosis of the jaw].
    Koy S; Schubert M; Koy J; Ney M; Lauer G; Sabatowski R
    Schmerz; 2015 Apr; 29(2):171-8. PubMed ID: 25860198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral bisphosphonate-related osteonecrosis of the jaw: the first report in Asia.
    Hong JW; Nam W; Cha IH; Chung SW; Choi HS; Kim KM; Kim KJ; Rhee Y; Lim SK
    Osteoporos Int; 2010 May; 21(5):847-53. PubMed ID: 19633881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: A trigger for BRONJ development?
    Otto S; Tröltzsch M; Jambrovic V; Panya S; Probst F; Ristow O; Ehrenfeld M; Pautke C
    J Craniomaxillofac Surg; 2015 Jul; 43(6):847-54. PubMed ID: 25958767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is bone turnover of jawbone and its possible over suppression by bisphosphonates of etiologic importance in pathogenesis of bisphosphonate-related osteonecrosis?
    Ristow O; Gerngroß C; Schwaiger M; Hohlweg-Majert B; Kehl V; Jansen H; Hahnefeld L; Otto S; Pautke C
    J Oral Maxillofac Surg; 2014 May; 72(5):903-10. PubMed ID: 24485975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonate-Related Osteonecrosis of the Jaw.
    Chien HI; Chen LW; Liu WC; Lin CT; Ho YY; Tsai WH; Yang KC
    Ann Plast Surg; 2021 Feb; 86(2S Suppl 1):S78-S83. PubMed ID: 33346545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dental extraction as a risk factor for bisphosphonate related osteonecrosis of the jaw in cancer patients: an update.
    Utreja A; Almas K; Javed F
    Odontostomatol Trop; 2013 Jun; 36(142):38-46. PubMed ID: 24073539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.